Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 49,500 shares at $99.77 ($4.8M) on 2020-12-14, disclosed to the SEC on 2020-12-15.
Open-market sale of $4.8M FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.89 | 1,813 | $174K | 3.6% |
| 2 | $95.89 | 1,813 | $174K | 3.6% |
| 3 | $96.65 | 11,765 | $1.1M | 23.5% |
| 4 | $96.65 | 11,765 | $1.1M | 23.5% |
| 5 | $97.70 | 2,946 | $288K | 5.9% |
| 6 | $97.70 | 2,946 |
| $288K |
| 5.9% |
| 7 | $98.80 | 3,148 | $311K | 6.4% |
| 8 | $98.80 | 3,148 | $311K | 6.4% |
| 9 | $99.77 | 3,822 | $381K | 7.9% |
| 10 | $99.77 | 3,822 | $381K | 7.9% |
| 11 | $100.97 | 400 | $40K | 0.8% |
| 12 | $102.06 | 1,006 | $103K | 2.1% |
| 13 | $102.06 | 1,006 | $103K | 2.1% |
| 14 | $102.75 | 100 | $10K | 0.2% |
| Total | $97.74 avg | 49,500 | $4.8M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |